Globus Medical, Inc.
GMEDNYSEHealthcare● Active
$80.00
+$0.00(+0.00%)
Market Cap$10.8B
P/E Ratio—
52W High$101.4
52W Low$51.79
Globus Medical, Inc. (GMED) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GMED · as of 2026-06-08
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.54B | $0.10B | $0.12B | $0.19B | $0.15B |
| Depreciation & Amort. | $0.28B | $0.25B | $0.14B | $0.07B | $0.07B |
| Stock-Based Comp. | $0.05B | $0.05B | $0.05B | $0.03B | $0.03B |
| Change in Working Capital | ($0.08B) | ($0.10B) | ($0.12B) | ($0.11B) | ($0.02B) |
| Net Cash from Operations | $0.75B | $0.52B | $0.24B | $0.18B | $0.28B |
| Investing Activities | |||||
| Capital Expenditure | ($0.16B) | ($0.12B) | ($0.08B) | ($0.07B) | ($0.06B) |
| Purchases of Investments | ($0.11B) | ($0.11B) | ($0.10B) | ($0.42B) | ($0.62B) |
| Sales of Investments | $0.18B | $0.07B | $0.78B | $0.41B | $0.34B |
| Net Cash from Investing | ($0.36B) | ($0.18B) | $0.30B | ($0.11B) | ($0.38B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.30B) | ($0.09B) | ($0.23B) | ($0.14B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | ($0.68B) | ($0.03B) | ($0.23B) | ($0.11B) | $0.05B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.59B | $0.41B | $0.17B | $0.10B | $0.22B |
| FCF Margin %(computed) | 20.03% | 16.08% | 10.53% | 10.21% | 22.90% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Globus Medical, Inc. data
About Globus Medical, Inc. (GMED) Cash Flow Statement
Globus Medical, Inc. generated operating cash flow of $0.75B and free cash flow of $0.59B for 2025 — a FCF margin of 20.03%. Capital expenditure was ($0.16B).
Frequently asked questions
GMED · 4 questionsGlobus Medical, Inc. generated free cash flow of $0.59B for 2025, up 45.3% year-over-year.
GMED free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08